Lumi Thera
Medical Devices, 4058 Ne Lookout Ln, Poulsbo, Washington, 98370, United States, 1-10 Employees
Phone Number: 13*********
Who is LUMITHERA
At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We w...
Read More
-
Headquarters: 4058 Ne Lookout Ln, Poulsbo, Washington, 98370, United States
-
Employees: 1-10
-
Revenue: $10 Million to $25 Million
-
CEO:
Clark Tedford
Email
Phone
Industry: Medical Devices
SIC Code: 5047
LumiThera Org Chart and Mapping
Similar Companies to LumiThera
AdaptDx Pro
-
11-50
-
$ 25 Million to 50 Million
Carthera
-
1-10
-
$ 1 Million to 5 Million
Heru
-
51-200
-
$ 25 Million to 50 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding LumiThera
Answer: LumiThera's headquarters are located at 4058 Ne Lookout Ln, Poulsbo, Washington, 98370, United States
Answer: LumiThera's phone number is 13*********
Answer: LumiThera's official website is https://lumithera.com
Answer: LumiThera's revenue is $10 Million to $25 Million
Answer: LumiThera's SIC: 5047
Answer: LumiThera has 1-10 employees
Answer: LumiThera is in Medical Devices
Answer: LumiThera top competitors include: AdaptDx Pro , Carthera , Heru
Answer: LumiThera contact info: Phone number: 13********* Website: https://lumithera.com
Answer: At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Companys expertise is in the application of photobiomodulation (PBM), using non-invasive light emitting diodes (LED) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological drusen following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month